- Home
- GOOS vs CVAC Comparison
GOOS vs CVAC Comparison
Compare GOOS & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOOS
- CVAC
- Stock Information
- Founded
- GOOS 1957
- CVAC 2000
- Country
- GOOS Canada
- CVAC Germany
- Employees
- GOOS N/A
- CVAC N/A
- Industry
- GOOS
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- GOOS
- CVAC Health Care
- Exchange
- GOOS Nasdaq
- CVAC Nasdaq
- Market Cap
- GOOS 1.1B
- CVAC 1.2B
- IPO Year
- GOOS 2017
- CVAC 2020
- Fundamental
- Price
- GOOS $14.04
- CVAC $5.41
- Analyst Decision
- GOOS Hold
- CVAC Hold
- Analyst Count
- GOOS 5
- CVAC 3
- Target Price
- GOOS $11.25
- CVAC $6.83
- AVG Volume (30 Days)
- GOOS 1.0M
- CVAC 974.0K
- Earning Date
- GOOS 07-31-2025
- CVAC 08-14-2025
- Dividend Yield
- GOOS N/A
- CVAC N/A
- EPS Growth
- GOOS 70.17
- CVAC N/A
- EPS
- GOOS 0.68
- CVAC 0.87
- Revenue
- GOOS $943,742,214.00
- CVAC $566,039,775.00
- Revenue This Year
- GOOS $4.27
- CVAC N/A
- Revenue Next Year
- GOOS $5.83
- CVAC $24.04
- P/E Ratio
- GOOS $20.19
- CVAC $6.26
- Revenue Growth
- GOOS 1.09
- CVAC 787.60
- 52 Week Low
- GOOS $6.73
- CVAC $2.37
- 52 Week High
- GOOS $14.28
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- GOOS 74.49
- CVAC 61.38
- Support Level
- GOOS $13.54
- CVAC $5.42
- Resistance Level
- GOOS $14.28
- CVAC $5.49
- Average True Range (ATR)
- GOOS 0.50
- CVAC 0.07
- MACD
- GOOS 0.20
- CVAC -0.06
- Stochastic Oscillator
- GOOS 91.91
- CVAC 52.38
About GOOS Canada Goose Holdings Inc. Subordinate Voting Shares
Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale and Direct to Consumer (DTC), Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia, and Europe, the Middle East, and Africa.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.